Vera Bittner
University of Alabama · 683 works · 49,305 citations · h-index 100
Top works
- Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators
- Prediction of Mortality and Morbidity With a 6-Minute Walk Test in Patients With Left Ventricular Dysfunction
- Exercise Standards for Testing and Training
- HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events
- Triglycerides and Cardiovascular Disease
- Core Components of Cardiac Rehabilitation/Secondary Prevention Programs: 2007 Update
- Effects of Hormone Replacement Therapy and Antioxidant Vitamin Supplements on Coronary Atherosclerosis in Postmenopausal Women
- The 6-min Walk Test*
- Resistance Exercise in Individuals With and Without Cardiovascular Disease: 2007 Update
- 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
- Population Approaches to Improve Diet, Physical Activity, and Smoking Habits
- Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: The studies of left ventricular dysfunction
- Insights From the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study
- Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
- Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial
- Insights From the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study
- Glycemic Effects of Postmenopausal Hormone Therapy: The Heart and Estrogen/progestin Replacement Study: A Randomized, Double-Blind, Placebo-Controlled Trial
- Referral, Enrollment, and Delivery of Cardiac Rehabilitation/Secondary Prevention Programs at Clinical Centers and Beyond